Dr. Jason E. Zucker, MD

Dr. Zucker practices at Columbia University Irving Medical Center in New York, New York.

Dr. Zucker's NPI, 1306162995, was assigned on April 8, 2010. Dr. Zucker graduated from Rutgers New Jersey Medical School in 2010. Dr. Zucker holds New York license 279819.

Dr. Zucker's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Zucker's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Zucker is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Zucker to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zucker practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Zucker's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Zucker is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Zucker's licenses on file in 2 states: New York and New Jersey.

CMS data shows 22 Medicare services from Dr. Zucker across 1 procedure code in 2024, for 21 Medicare patients. Medicare paid $2,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Zucker in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 5.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zucker's median patient age at 36, with 33% women.

In 2022, Dr. Zucker wrote 11 Medicare Part D claims. They cover 1 drug, with $43,280 in total drug cost. In 2021, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zucker for performance year 2024, reported through an alternative payment model (APM). Dr. Zucker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 160 papers to Dr. Zucker, published from 2016 to 2025. 2020 was the busiest year, with 25. The most frequent topics are COVID-19, HIV Infections and New York City. Dr. Zucker has published most often in Open Forum Infect Dis. Dr. Zucker's most frequent co-authors are Magdalena Elzbieta Sobieszczyk, MD, Alwyn Cohall, MD and Michael Ting-Pong Yin, MD.

CMS Open Payments shows 3 general payments to Dr. Zucker from 2 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $9,433.

Dr. Zucker graduated from Rutgers New Jersey Medical School in 2010.

Dr. Zucker is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.